Cargando…
Conservative Management of Presumed Fetal Anemia Secondary to Maternal Chemotherapy for Acute Myeloid Leukemia
Acute myeloid leukemia occurs rarely during pregnancy. When it is diagnosed remote from term, treatment in the form of daunorubicin plus cytarabine induction with consolidative cytarabine is typically undertaken after the first trimester. There is little data to guide fetal monitoring, in particular...
Autores principales: | Nowik, Christina M., Gerrie, Alina S., Wong, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical Publishers, Inc.
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674095/ https://www.ncbi.nlm.nih.gov/pubmed/34925954 http://dx.doi.org/10.1055/s-0041-1740561 |
Ejemplares similares
-
Autoimmune Hemolytic Anemia in Chronic Myeloid Leukemia
por: Hamamyh, Tahseen, et al.
Publicado: (2020) -
Resolution of Neonatal Hypertrophic Cardiomyopathy Presumed Secondary to Acquired Maternal Ribonucleoprotein and Smith Autoantibodies
por: Shah, A., et al.
Publicado: (2013) -
Severity of Anemia During Pregnancy and Adverse Maternal and Fetal Outcomes
por: Shi, Huifeng, et al.
Publicado: (2022) -
Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia
por: Dumas, Pierre-Yves, et al.
Publicado: (2017) -
The importance of the immunohematologic evaluation for presumed autoimmune hemolytic anemia in the COVID-19 era
por: Jacobs, Jeremy W., et al.
Publicado: (2023)